Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.
Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle and RNA polymerase II mediated transcription. Several pharmacological CDK inhibitors are currently in clinical trials as potential cancer therapeutics and some of them also exhibit antiviral effects. Olomoucine II and roscovitine,...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0089228 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850125452135366656 |
|---|---|
| author | Jitka Holcakova Petr Muller Peter Tomasec Roman Hrstka Marta Nekulova Vladimir Krystof Miroslav Strnad Gavin W G Wilkinson Borivoj Vojtesek |
| author_facet | Jitka Holcakova Petr Muller Peter Tomasec Roman Hrstka Marta Nekulova Vladimir Krystof Miroslav Strnad Gavin W G Wilkinson Borivoj Vojtesek |
| author_sort | Jitka Holcakova |
| collection | DOAJ |
| description | Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle and RNA polymerase II mediated transcription. Several pharmacological CDK inhibitors are currently in clinical trials as potential cancer therapeutics and some of them also exhibit antiviral effects. Olomoucine II and roscovitine, purine-based inhibitors of CDKs, were described as effective antiviral agents that inhibit replication of a broad range of wild type human viruses. Olomoucine II and roscovitine show high selectivity for CDK7 and CDK9, with important functions in the regulation of RNA polymerase II transcription. RNA polymerase II is necessary for viral transcription and following replication in cells. We analyzed the effect of inhibition of CDKs by olomoucine II on gene expression from viral promoters and compared its effect to widely-used roscovitine. We found that both roscovitine and olomoucine II blocked the phosphorylation of RNA polymerase II C-terminal domain. However the repression of genes regulated by viral promoters was strongly dependent on gene localization. Both roscovitine and olomoucine II inhibited expression only when the viral promoter was not integrated into chromosomal DNA. In contrast, treatment of cells with genome-integrated viral promoters increased their expression even though there was decreased phosphorylation of the C-terminal domain of RNA polymerase II. To define the mechanism responsible for decreased gene expression after pharmacological CDK inhibitor treatment, the level of mRNA transcription from extrachromosomal DNA was determined. Interestingly, our results showed that inhibition of RNA polymerase II C-terminal domain phosphorylation increased the number of transcribed mRNAs. However, some of these mRNAs were truncated and lacked polyadenylation, which resulted in decreased translation. These results suggest that phosphorylation of RNA polymerase II C-terminal domain is critical for linking transcription and posttrancriptional processing of mRNA expressed from extrachromosomal DNA. |
| format | Article |
| id | doaj-art-2a0eb9b76b514b0ab1663cf7cb230cc2 |
| institution | OA Journals |
| issn | 1932-6203 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-2a0eb9b76b514b0ab1663cf7cb230cc22025-08-20T02:34:07ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0192e8922810.1371/journal.pone.0089228Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.Jitka HolcakovaPetr MullerPeter TomasecRoman HrstkaMarta NekulovaVladimir KrystofMiroslav StrnadGavin W G WilkinsonBorivoj VojtesekCyclin-dependent kinases (CDKs) are key regulators of the cell cycle and RNA polymerase II mediated transcription. Several pharmacological CDK inhibitors are currently in clinical trials as potential cancer therapeutics and some of them also exhibit antiviral effects. Olomoucine II and roscovitine, purine-based inhibitors of CDKs, were described as effective antiviral agents that inhibit replication of a broad range of wild type human viruses. Olomoucine II and roscovitine show high selectivity for CDK7 and CDK9, with important functions in the regulation of RNA polymerase II transcription. RNA polymerase II is necessary for viral transcription and following replication in cells. We analyzed the effect of inhibition of CDKs by olomoucine II on gene expression from viral promoters and compared its effect to widely-used roscovitine. We found that both roscovitine and olomoucine II blocked the phosphorylation of RNA polymerase II C-terminal domain. However the repression of genes regulated by viral promoters was strongly dependent on gene localization. Both roscovitine and olomoucine II inhibited expression only when the viral promoter was not integrated into chromosomal DNA. In contrast, treatment of cells with genome-integrated viral promoters increased their expression even though there was decreased phosphorylation of the C-terminal domain of RNA polymerase II. To define the mechanism responsible for decreased gene expression after pharmacological CDK inhibitor treatment, the level of mRNA transcription from extrachromosomal DNA was determined. Interestingly, our results showed that inhibition of RNA polymerase II C-terminal domain phosphorylation increased the number of transcribed mRNAs. However, some of these mRNAs were truncated and lacked polyadenylation, which resulted in decreased translation. These results suggest that phosphorylation of RNA polymerase II C-terminal domain is critical for linking transcription and posttrancriptional processing of mRNA expressed from extrachromosomal DNA.https://doi.org/10.1371/journal.pone.0089228 |
| spellingShingle | Jitka Holcakova Petr Muller Peter Tomasec Roman Hrstka Marta Nekulova Vladimir Krystof Miroslav Strnad Gavin W G Wilkinson Borivoj Vojtesek Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy. PLoS ONE |
| title | Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy. |
| title_full | Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy. |
| title_fullStr | Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy. |
| title_full_unstemmed | Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy. |
| title_short | Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy. |
| title_sort | inhibition of post transcriptional rna processing by cdk inhibitors and its implication in anti viral therapy |
| url | https://doi.org/10.1371/journal.pone.0089228 |
| work_keys_str_mv | AT jitkaholcakova inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT petrmuller inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT petertomasec inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT romanhrstka inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT martanekulova inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT vladimirkrystof inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT miroslavstrnad inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT gavinwgwilkinson inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy AT borivojvojtesek inhibitionofposttranscriptionalrnaprocessingbycdkinhibitorsanditsimplicationinantiviraltherapy |